Methods for detecting structural variants in neurodegenerative disease
Provided herein according to some embodiments is a method for detecting a short tandem repeat (STR) variant in the SOD1, TARDBP or C9orf72 gene region comprising measuring the length of the STR variant. In some embodiments, the method V includes obtaining a biological sample containing genomic DNA from a subject, optionally isolating the genomic DNA from the sample. Also provided is a method for determining a diagnosis or a prognosis for a neurodegenerative disease, including: measuring a length of a short tandem repeat (STR) variant in the SOD1, TARDBP or C9orf72 gene region, and determining the diagnosis or prognosis based upon the length. Further provided is a method of treatment for a neurodegenerative disease including: administering a therapeutic agent to a subject based upon a length of a short tandem repeat (STR) variant in the SOD1, TARDBP or C9orf72 gene region in the subject. Also provided is a kit for detecting a (STR) variant in the SOD1, TARDBP or C9orf72 gene region.
1. A method for detecting a simple sequence repeat (SSR) variant of a subject, said method comprising:
obtaining a biological sample from the subject, said sample comprising genomic DNA,
isolating said genomic DNA from said sample, and
measuring the length of the SSR variant, wherein the SSR variant of the subject is 14, 15, or 18 poly-T or poly-A residues at SV1, and
wherein said measuring comprises Sanger DNA sequencing, a size-based assay, or both.
2. The method of claim 1 , wherein said measuring comprises nested PCR.
3. The method of claim 1 , wherein said method comprises genotyping by measuring the length of the SSR variant at each allele (phased or unphased).
4. The method of claim 1 , wherein the SV1 variant of the subject has a poly-T or poly-A length of 18.
5. The method of claim 1 , wherein said measuring comprises gel or capillary electrophoresis.